Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma-Reference-Cited by-同舟云学术

Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma

Published:2018-05-25 Issue:40 Volume:9 Page:25764-25780
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Bu De-Xiu¹,Singh Reshma¹,Choi Eugene E.¹,Ruella Marco²,Nunez-Cruz Selene²,Mansfield Keith G.¹,Bennett Paul¹,Barton Nathanial¹,Wu Qilong³,Zhang Jiquan³,Wang Yongqiang³,Wei Lai³,Cogan Shawn¹,Ezell Tucker¹,Joshi Shree¹,Latimer Kellie J.¹,Granda Brian¹,Tschantz William R.¹,Young Regina M.²,Huet Heather A.¹,Richardson Celeste J.¹,Milone Michael C.²⁴

Affiliation:

1. Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA

2. Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA

3. China Novartis Institutes for Biomedical Research, Shanghai 201203, China

4. Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human IL-6 fosters long-term engraftment of patient-derived disease-driving myeloma cells in immunodeficient mice;JCI Insight;2024-05-07

2. Therapeutic potential of third-generation chimeric antigen receptor T cells targeting B cell maturation antigen for treating multiple myeloma;Clinical and Experimental Medicine;2024-04-29

3. Soluble B‐cell maturation antigen in multiple myeloma;American Journal of Hematology;2024-01-25

4. Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma;Leukemia;2024-01-06

5. NK92 Expressing Anti-BCMA CAR and Secreted TRAIL for the Treatment of Multiple Myeloma: Preliminary In Vitro Assessment;Cells;2023-11-30